MedCity Pivot

Reporters at MedCity News discuss their coverage areas interests and share what pitches are interesting and what is not. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sarah Boyce https://www.linkedin.com/in/sarah-boyce-7775808/ http://www.aviditybiosciences.com/about-us/ 

Arundhati interviewed Dr. Robert Pearl who has written a book about how physician culture needs to be urgently reformed to benefit both patients and the healthcare industry. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Robert Pearl drrobertpearl@gmail.com https://robertpearlmd.com/uncaring/ 

Arundhati interviewed Dr. Erich Huang, Chief Data Officer for Quality at Duke Health, and the Director of Duke Forge. They talk about why more hospitals are implementing machine learning tools for healthcare, and the challenges of ensuring these models do not yield biased results. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Erich Huang https://forge.duke.edu/erich-s-huang-md-phd https://www.linkedin.com/in/erichhuang/ 

Arundhati interviewed Glen Tullman to talk about his new venture and how he wants to transform the employee benefits and care navigation market. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Arundhati interviewed Ho Cho, senior vice president of Discovery Biotherapeutics at BMS talking about drug discovery and the interesting therapies that BMS is developing to treat myeloma and lupus. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Ho Cho https://www.linkedin.com/in/ho-cho-9173162/ 

Arundhati interviews Sean Slovenski, CEO of BioiQ, and they talk about how Covid-19 has affected the world of diagnostics and at-home testing. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sean Slovenski sslovenski@bioiq.com tj@thinkrevivehealth.com 

Arundhati interviewed Dr. Ami Bhatt, a cardiologist with Mass General Brigham, about the value of virtual care. Dr. Ami Bhatt specializes in lifelong care and empowerment of Teens and Adults with Congenital Heart Disease. He addresses valve problems, heart failure, multidisciplinary surgery, arrhythmia, pregnancy, transition, telemedicine & wellness programs.   Dr. Bhatt is an active clinical cardiologist, clinical investigator, and educator. She graduated from Harvard University, obtained her doctoral degree from Yale School of Medicine, and then trained at BWH. She works at the Children's Hospital of Boston and Mass General in internal medicine, pediatrics, cardiology, and adult congenital heart disease (ACHD).   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Ami Bhatt abhatt@mgh.harvard.edu

Arundhati interviewed Sree Chaguturu, chief medical officer of CVS Caremark and they discussed Covid-19 testing and vaccine distribution among other things.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sree Chaguturu https://twitter.com/chaguturu?lang=en  https://www.linkedin.com/in/sreekanth-chaguturu-9929ab4 

Arundhati interviewed Daniel Levner, co-founder of Sight Diagnostics, to talk about how machine learning can transform the field of complete blood count testing.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Daniel Levner https://www.sightdx.com/international  https://www.linkedin.com/company/sight-diagnostics/  levner@sightdx.com  judy@sightdx.com